The rodent ventrobasal (VB) thalamus contains a relatively uniform population of thalamocortical (TC) neurons that receive glutamatergic input from the vibrissae and the somatosensory cortex, and inhibitory input from the nucleus reticularis thalami (nRT). In this study we describe c-aminobutyric acid (GABA) A receptor-dependent slow outward currents (SOCs) in TC neurons that are distinct from fast inhibitory postsynaptic currents (IPSCs) and tonic currents. SOCs occurred spontaneously or could be evoked by hypo-osmotic stimulus, and were not blocked by tetrodotoxin, removal of extracellular Ca 2+ or bafilomycin A1, indicating a nonsynaptic, non-vesicular GABA origin. SOCs were more common in TC neurons of the VB compared with the dorsal lateral geniculate nucleus, and were rarely observed in nRT neurons, whilst SOC frequency in the VB increased with age. Application of THIP, a selective agonist at d-subunit-containing GABA A receptors, occluded SOCs, whereas the benzodiazepine site inverse agonist b-CCB had no effect, but did inhibit spontaneous and evoked IPSCs. In addition, the occurrence of SOCs was reduced in mice lacking the dsubunit, and their kinetics were also altered. The anti-epileptic drug vigabatrin increased SOC frequency in a time-dependent manner, but this effect was not due to reversal of GABA transporters. Together, these data indicate that SOCs in TC neurons arise from astrocytic GABA release, and are mediated by d-subunit-containing GABA A receptors. Furthermore, these findings suggest that the therapeutic action of vigabatrin may occur through the augmentation of this astrocyte-neuron interaction, and highlight the importance of glial cells in CNS (patho) physiology.
Introduction c-Aminobutyric acid (GABA)ergic signalling in the thalamus is central to controlling the relay of sensory information to the cortex, and in shaping behavioural state-dependent (patho)physiological cortico-thalamocortical (TC) oscillations (Huguenard & McCormick, 2007) . The rodent somatosensory ventrobasal (VB) thalamus contains a relatively uniform population of glutamatergic TC neurons, and unlike most thalamic nuclei is devoid of GABAergic interneurons (Barbaresi et al., 1986; Harris & Hendrickson, 1987) . Instead, inhibitory input originates from the nucleus reticularis thalami (nRT), which contains only GABAergic neurons (Spreafico et al., 1991) . TC neurons of the VB exhibit two types of GABA A receptor-mediated inhibition: classical fast inhibitory postsynaptic currents (IPSCs), generated by synaptic receptors; and a persistent or tonic current generated by a population of extrasynaptic receptors that are activated by ambient GABA (Brown et al., 2002; Belelli et al., 2005; Cope et al., 2005 , Cope et al., 2009 Jia et al., 2005; Chandra et al., 2006; Peden et al., 2008) . Importantly, different receptor subtypes underlie the two types of inhibition, synaptic receptors contain a1b2c2-subunits, whereas a4b2d-subunits comprise extrasynaptic receptors (Jia et al., 2005; Herd et al., 2009) . Indeed, the d-subunit is located exclusively extrasynaptically and conveys properties on these receptors ideally suited to the generation of tonic currents, particularly slow desensitization and a high affinity for GABA (Saxena & Macdonald, 1994) . Despite this high affinity, GABA itself is only a partial agonist at d-subunit-containing receptors, compared with the hypnotic THIP (Gaboxadol), which is a full, selective agonist at these receptors (Brown et al., 2002; Ebert et al., 2006; Storustovu & Ebert, 2006) . Given the molecular, pharmacological and anatomical distinctions between synaptic and extrasynaptic GABA A receptors, they most likely subserve different functions in thalamic (patho)physiological processes (e.g. Cope et al., 2009) . Astrocytes are already known to play pivotal roles in the regulation of GABAergic signalling in the somatosensory thalamus as they are the only cell type in this rodent nucleus to express GABA uptake transporters (De Biasi et al., 1998) . They therefore form a crucial link in the GABA-glutamine pathway with their uptake of GABA and its subsequent catabolism to glutamine, which is then supplied to nRT afferent presynaptic terminals.
Despite substantial interest in the identity of GABA targets in the thalamus, the sources of GABA that activate GABA A receptors in TC neurons of the VB have not been thoroughly explored. Whilst it is clear that synaptic receptors are directly activated by the vesicular of release of GABA from nRT terminals, whether GABA spillover from these terminals is the sole source of ambient GABA for extrasynaptic receptors has yet to be determined. Non-synaptic sources of GABA, including the reversal of GABA transporters (GATs; Wu et al., 2001 Wu et al., , 2003 Wu et al., , 2007 , have been implicated in other brain regions and, in the olfactory bulb, astrocytes release GABA, probably via a volumeregulated anion channel mechanism (Kozlov et al., 2006) . In the VB thalamus, astrocytes can also release gliotransmitters, most notably glutamate that can generate slow inward currents (SICs) in TC neurons and modulate their function (Parri et al., 2001) . However, the possibility that astrocytes are a source of GABA in the thalamus has not been evaluated. In this study, we describe spontaneous, transient, non-synaptic slow outward currents (SOC) in TC neurons that are generated by the release of GABA from astrocytes. Despite being transient, SOC are not mediated by synaptic receptors but by dsubunit-containing extrasynaptic GABA A receptors, and are upregulated by the anti-epileptic vigabatrin.
Materials and methods
All procedures were carried out in accordance with the UK Animals (Scientific Procedures) Act 1986 and associated procedures.
Slice preparation
Experiments were performed on postnatal day (P)10-23 for male Wistar rats, and P27-40 for male and female d-subunit knockout mice (d KO) and wild-type (WT) littermates. d KO and WT mice were genotyped as described previously (Cope et al., 2009) . Horizontal slices (300-350 lm) of VB thalamus were prepared as described previously (Parri et al., 2001) in ice-cold, continuously oxygenated (95% O 2 : 5% CO 2 ) modified artificial cerebrospinal fluid (ACSF) of composition (in mm): NaCl, 126; NaHCO 3 , 26; KCl, 1; KH 2 PO 4 , 1.25; MgSO 4 , 5; CaCl 2 , 1; glucose, 10. Slices were then maintained at room temperature (20 -24°C) in this solution for a recovery period of 1 h before experimental use.
Solutions
The standard, continuously oxygenated (95% O 2 : 5% CO 2 ) ACSF used in this study contained (in mm): NaCl, 126; NaHCO 3 , 24; KCl, 2.5; KH 2 PO 4 , 1.25; MgSO 4 , 1; CaCl 2 , 2; glucose, 10; unless otherwise stated. Hypo-osmotic stimulus was a 20% decrease in ACSF osmolarity. For experiments where glutamatergic SICs were recorded, Mg 2+ was omitted to enhance detection (Parri et al., 2001) . Tetrodotoxin (TTX) was included in ACSF and hypo-osmotic (h)ACSF in all experiments, except where IPSCs were recorded, and current-clamp experiments. Chemicals for ASCF preparation were obtained from Sigma (St Louis, MO, USA). Pharmacological compounds were included in the ACSF as stated in the text. In the case of Bafilomycin incubation, slices were pretreated in storage ACSF containing 45 lm Bafilomycin A1 for 1-2 h prior to recording. Drugs were obtained from the following sources: (±)-c-vinyl GABA (vigabatrin), 4,5,6,7-tetrahydroisoxazolo[5,4- 
,6-tetrahydro-3-pyridinecarboxy lic acid hydrochloride (NO711) and 1-[2-[tris(4-methoxyphenyl)meth oxy]ethyl]-(S)-3-piperidinecarboxylic acid (SNAP5114) were obtained from Tocris (Bristol, UK); TTX and 2-(3-carboxypropyl)-3-amino-6-(4 methoxyphenyl)pyridazinium bromide (SR95531) were obtained from Ascent (Weston-super-Mare, UK); kynurenic acid was obtained from Sigma-Aldrich (Poole, Dorset, UK).
Electrophysiological recordings
The recording chamber and manipulators were mounted on a moveable bridge (Luigs and Neumann, Ratingen, Germany). Slices were visualized by DIC using a Nikon FN1 microscope with a · 40 0.8 NA water dipping lens. Patch-clamp recordings of SOCs were made at room temperature (20 -24°C), or at 33 ± 1°C where indicated, using pipettes (2-4 MX) containing a high Cl ) internal solution of composition (in mm): KCl, 125; NaCl, 10; MgCl 2 , 2; CaCl 2 , 1; HEPES, 10; EGTA, 10; Na 2 ATP, 4; GTP, 0.3. For experiments in d KO and WT mice, pipettes contained (in mm): CsCl, 130; MgCl 2 , 2; Mg-ATP, 4; Na-GTP, 0.3; HEPES, 10; EGTA, 0.1. To block possible contamination by N-methyld-aspartate (NMDA) receptor-mediated SICs, either kynurenic acid (3 mm) was included in the ACSF, or MK801 (1 mm) was included in the patch solution (Berretta & Jones, 1996) . Current traces from such recordings are displayed inverted to maintain the convention of GABAergic SOCs being outward. Experiments aimed at concomitantly recording both SICs and SOCs and investigating the physiological impact of SOC-mediated hyperpolarizations in current-clamp mode were conducted using intracellular solution containing (in mm): KMeSO 4 , 120; KCl, 5; HEPES, 10; EGTA, 0.1; Na 2 ATP, 4; GTP, 0.5. Intracellular Cl concentration (5 mm) was included to set physiological E Cl in these cells (Ulrich & Huguenard, 1997) . Tonic current was measured by rapidly introducing the GABA A antagonist SR95531 to the recording chamber and measuring the resultant change in holding current. Synaptic stimulation was achieved with a computer-controlled constant current-isolated stimulator (STG1002; Multichannel Systems, Germany) and bipolar electrodes placed on the internal capsule. Neuronal currents were recorded using a Multiclamp 700B amplifier, digitized with a Digidata 1440A, and acquired and analysed using pClamp software (Molecular Devices, CA, USA). IPSCs and SOCs were analysed using the Event Detection protocols in Clampfit. Events were classed as SOCs if their amplitude was > 20 pA and their time to peak was > 20 ms. Data were exported to Sigmaplot (Jandel) for further analysis and plotting.
Statistics
All quantitative data in the text and figures are presented as mean ± SEM. Significance was calculated using unpaired or paired Student's t-test as appropriate. Kolmogorov-Smirnov tests were used for population distribution comparisons. Linear correlations were tested using Spearman's Rank correlation. The statistical significance in figures is presented as *P < 0.05, **P < 0.01, ***P < 0.005.
Results
Astrocytic GABA release generates SOCs via GABA A receptors Patch-clamp recordings were made from TC neurons in the VB thalamus at ages P10-23. In addition to previously described spontaneous SICs (sSICs), corresponding to the activation of NMDA receptors by astrocytically derived glutamate ( Fig. 1A ; Parri et al., 2001) , in some experiments (25 out of 42 recordings) we were able to concomitantly record spontaneous, transient outward currents that had very slow rise times and durations of hundreds of milliseconds (Fig. 1A) . Because of their similarity to the SOCs previously described in the olfactory bulb (Kozlov et al., 2006) , we adopted the nomenclature of Kozlov et al. to identify them. The observed incidence of spontaneous SOCs (sSOCs; 0.02 ± 0.01 SOCs ⁄ min) was significantly lower than that of sSICs (0.10 ± 0.03 SICs ⁄ min; P < 0.05; Fig. 1A ).
To focus on these outward inhibitory currents, subsequent experiments were performed using pipettes containing high Cl ) in order to isolate and enhance the detection of Cl -mediated currents (see Materials and methods). Under such conditions, spontaneous IPSCs were readily observed, as described previously (Le Feuvre et al., 1997) . IPSCs had a mean frequency of 15.60 ± 4.21 Hz (n = 5 neurons), a mean time to peak of 2.45 ± 0.14 ms and mean amplitude of 80.70 ± 4.66 pA (n = 250 events, pooled from five neurons; Fig. 1B ). IPSC frequency was significantly lower in the presence of TTX (1 lm) to block action potential-dependent GABA release (21.96 ± 5.95% of control, n = 11 neurons; P < 0.05), and following the removal of Ca 2+ from the ACSF to block voltage-dependent Ca 2+ entry (3.40 ± 3.00% of control, n = 5 neurons; P < 0.05; Fig. 1C ). Furthermore, application of the selective GABA A receptor antagonist SR95531 (25 lm) abolished all IPSCs (n = 4 neurons; Fig. 1C ). Thus, conventional synaptic GABA release, presumably from the axon terminals of nRT neurons, underlies the generation of IPSCs in TC neurons of the VB. In addition to spontaneous IPSCs, sSOCs could also be recorded using pipettes containing high Cl . The mean amplitude of the sSOCs (111.30 ± 31.27 pA, n = 52 events) was not significantly different to that of IPSCs, and the distribution of peak amplitudes was also not different (both P > 0.05; Fig. 1B) . However, the mean time to peak was significantly slower (108.90 ± 34.53 ms, n = 52 events; P < 0.001) and the distribution of rise times was also significantly different compared with IPSCs (P < 0.001; Fig. 1B ). In complete contrast to IPSCs, however, the frequency of sSOCs was not affected by application of TTX (control -0.29 ± 0.16 ⁄ min; TTX -0.25 ± 0.06 ⁄ min, n = 9 neurons; P > 0.05) or the removal of extracellular Ca 2+ (122.15 ± 63.56% of control, n = 6 neurons; Fig. 1C ), indicating a non-synaptic origin. To further investigate the source of GABA responsible for generating SOCs, we treated slices with bafilomycin A1, a depletor of vesicular neuro-and gliotransmitter release. Application of bafilomycin A1 did not significantly affect the frequency of sSOCs (control 0.27 ± 0.09 ⁄ min, n = 19 neurons; bafilomycin 0.38 ± 0.14 ⁄ min, n = 18 neurons; P > 0.05) or their amplitude (control 109.60 ± 18.58 pA, n = 24 neurons; bafilomycin 137.12 ± 11.34 pA, n = 10 neurons; P > 0.05), indicating that SOCs are dependent on a non-vesicular GABA release mechanism. sSOC frequency was also not affected by the combined block of ionotropic and metabotropic glutamate receptors following the application of D-AP5 (50 lm), NBQX or CNQX (20 lm), MTEP (10 lm), CPCCOEt (100 lm), LY341495 (2 lm) and MPPG (100 lm; control -0.24 ± 0.06 ⁄ min, n = 9 neurons; antagonists -0.21 ± 0.07 ⁄ min, n = 5 neurons). However, like IPSCs, sSOCs were completely abolished by the GABA A receptor antagonist SR95531 (n = 5 neurons; Fig. 1C ).
The incidence of sSOCs was low, with events only occurring every few minutes. We therefore attempted to increase their frequency by applying a hypo-osmotic stimulus, as described previously in the olfactory bulb (Kozlov et al., 2006) . Application of hACSF elicited evoked SOCs (eSOCs) at a frequency of 1.55 ± 0.43 ⁄ min (n = 14 neurons; P < 0.001 compared with sSOC frequency; Fig. 2A ). The mean rise time and mean amplitude of eSOCs (136.97 ± 19.66 ms and 134.19 ± 13.21 pA, respectively, n = 14 neurons) were not significantly different to sSOCs recorded in the same neurons (100.01 ± 19.65 ms and 109.60 ± 18.58 pA, respectively; both P > 0.05; Fig. 2A ). However, the population distributions for rise times and peak amplitudes were significantly different (P < 0.05 and P < 0.005, respectively), with the eSOC population containing larger, slower events ( Fig. 2A) . Bath application of SR95531 following hACSF application not only blocked all eSOCs but also revealed a large tonic GABA A receptor-mediated current compared with normal, control ACSF (control -14.30 ± 7.06 pA, n = 8 neurons; hACSF -168.10 ± 28.36 pA, n = 8 neurons; P < 0.005; Fig. 2A ). Thus, GABA release caused by hypo-osmotic stimulation not only increases the incidence of SOCs but also contributes to tonic GABA A inhibition. Application of SR95531 before the hypo-osmotic stimulus prevented the generation of eSOCs (control -0.67 ± 0.14 mC, n = 8 neurons; SR95531 -0.06 ± 0.04 mC, n = 5 neurons; P < 0.01; Fig. 2B ), confirming that eSOCs, like sSOCs, are exclusively mediated by GABA A receptors.
In summary, these results show that SOCs are GABA A receptormediated events that have markedly different properties to GABA A receptor-mediated IPSCs, notably occurrence, onset and duration (Figs 1 and 2). In addition, whereas IPSCs are sensitive to TTX, external Ca 2+ concentration and bafilomycin A1, SOCs are insensitive to all three of these manipulations. Thus, IPSCs arise due to conventional vesicular GABA release from neuron terminals, but SOCs are dependent upon an alternate GABA source that is nonsynaptic and non-vesicular. These data, together with the sensitivity of SOCs to hypo-osmotic stimulation, suggest that SOCs are generated in response to the release of GABA from astrocytes, probably through a volume-regulated anion channel mechanism as previously implicated in the olfactory bulb (Kozlov et al., 2006) .
Nucleus-specific distribution and developmental profile of SOCs
To determine the functional expression of SOCs in the thalamus, we compared sSOCs and eSOCs in thalamic nuclei that have different anatomical and functional properties at the same age (P18-23) -the VB nucleus, which receives somatosensory input and is comprised solely of glutamatergic TC neurons (Barbaresi et al., 1986; Harris & Hendrickson, 1987) ; the dorsal lateral geniculate nucleus (dLGN), which receives visual input and contains a population of GABAergic interneurons in addition to TC neurons (Ohara et al., 1983) ; and the nRT, a thalamic nucleus comprised solely of GABAergic neurons (Spreafico et al., 1991; Fig. 3A) . sSOCs were most prevalent in the VB thalamus (0.20 ± 0.07 ⁄ min, n = 8 neurons), followed by the dLGN (0.03 ± 0.02 ⁄ min, n = 9 neurons) and then the nRT (0.02 ± 0.02 ⁄ min, n = 4 neurons; Fig. 2A and B). eSOCs also followed the same pattern, being most common in the VB (2.35 ± 0.63 ⁄ min, n = 8 neurons), followed by the dLGN (0.53 ± 0.18 ⁄ min, n = 9 neurons) and then the nRT (0.20 ± 0.04 ⁄ min, n = 5 neurons; Fig. 3A and B) . These data suggest that the VB has the greatest potential for nonsynaptic astrocytic GABA signalling, but also the greatest functional impact, as the total charge carried by eSOCs following hACSF application in the VB thalamus was significantly greater than in both the dLGN and the nRT (VB -0.67 ± 0.14 mC, n = 8 neurons; dLGN -0.19 ± 0.06 mC, n = 7 neurons; nRT -0.03 ± 0.02 mC, n = 4 neurons; VB vs. dLGN, P < 0.01; VB vs. nRT, P < 0.01; Fig. 3B ).
We also investigated sSOC frequency at different ages in TC neurons of the VB. sSOC frequency was significantly lower in TC neurons at P10 compared with P20 (P10 -0.30 ± 0.01 ⁄ min, n = 19 neurons; P20 -0.40 ± 0.05 ⁄ min, n = 11 neurons; P < 0.01; Fig. 3C ). eSOC frequency in response to hypo-osmotic stimulation was similar to sSOC frequency in neurons from P10 animals (0.49 ± 0.10 ⁄ min, n = 6 neurons), whereas the incidence of eSOCs was greater than sSOCs in neurons from P20 animals (2.35 ± 0.63 ⁄ min, n = 8 neurons). eSOC frequency was significantly different between the two ages (P < 0.01; Fig. 3B ). The occurrence of SOCs therefore exhibits both a nucleusspecific distribution, being more prevalent in the VB than both the dLGN and nRT, and a developmental emergence in the VB. Recording from another cell, with expanded traces below displaying fast IPSCs (grey) and a much slower, and unusually large-amplitude, SOC (black). Cumulative probability distributions of amplitude (upper) and time to peak (lower) for IPSCs (grey lines) and SOCs (black lines) are displayed on the right. (C) Traces from experiments displaying spontaneously recorded events in the presence of tetrodotoxin (TTX; 1 lm, left), TTX + 0 mm extracellular Ca 2+ (middle) and the GABA A antagonist SR95531 (25 lm, right). The bar graphs below show IPSC frequency (grey columns, left) and SOC frequency (black columns, right) normalized to control for each experimental condition. *indicates P < 0.05; *** indicates P < 0.005.
SOCs are generated by d-subunit-containing GABA A receptors TC neurons of the VB contain relatively few GABA A receptor subtypes. Synaptic receptors are comprised of a1b2c2-subunits and are responsible for the generation of IPSCs, whereas a4b2d receptors are present in the extrasynaptic membrane and generate tonic currents (Wong & Snead, 2001; Belelli et al., 2005; Jia et al., 2005; Chandra et al., 2006; Peden et al., 2008; Herd et al., 2009) . Both the nucleusspecific occurrence and developmental profile of SOCs mirrors the nucleus-specific distribution and postnatal development of the dsubunit, i.e. the d-subunit is strongly expressed in the VB and dLGN but is absent from the nRT (Pirker et al., 2000) , and postnatally the dsubunit is only present from P12 onward in rats (Laurie et al., 1992) . Because astrocytic glutamate release has been suggested to target extrasynaptic receptors (Halassa et al., 2007) , we therefore postulated that SOCs are generated by the activation of d-subunit-containing extrasynaptic receptors, as opposed to c2-subunit-containing synaptic receptors. To test the role of different GABA A receptor populations in the generation of SOCs we used the benzodiazepine site inverse agonist b-CCB to target synaptic receptors, and the d-subunit-selective agonist THIP to target extrasynaptic receptors. Application of b-CCB (1 lm, n = 4 neurons) caused a significant reduction in IPSC amplitude (control -93.90 ± 2.25 pA; b-CCB -69.40 ± 2.17 pA, 608 and 533 events, respectively; P < 0.005; Fig. 4A ). Evoked IPSCs generated by stimulation of the nRT were also significantly reduced by application of b-CCB (control -493.62 ± 101.87 pA; b-CCB -282.40 ± 94.92 pA, n = 6 neurons; P < 0.05; Fig. 4A) . Analysis of the effect of b-CCB on eSOCs (n = 4 neurons) showed a small, but significant, increase in amplitude (control -89.70 ± 9.11 pA; b-CCB -98.20 ± 10.30 pA, 188 and 204 events, respectively; P < 0.05), but no effect on frequency (control -7.11 ± 1.11 ⁄ min; b-CCB -8.37 ± 1.63 ⁄ min; Fig. 4B ). Thus, IPSCs are indeed generated by synaptic, c2-subunit-containing receptors, but SOCs are not dependent on this receptor population. Application of the d-subunit-selective agonist THIP (1 lm) resulted in a large tonic GABA A current (285.96 ± 63.12 pA, n = 9 neurons), as described previously (Belelli et al., 2005; Jia et al., 2005; Cope et al., 2009; Fig. 5A) . Following hACSF application in the presence of THIP, eSOCs occurred at a reduced frequency (hACSF -6.54 ± 1.72 ⁄ min, n = 7 neurons; hACSF + THIP -1.56 ± 0.73 ⁄ min, n = 8 neurons; P < 0.05; Fig. 5A ). In addition, the peak amplitude of eSOCs was significantly increased in the presence of THIP (hACSF -165.04 ± 16.20 pA, n = 286 events from seven neurons; hACSF + THIP -214.98 ± 30.32 pA, n = 83 events from eight neurons; P < 0.005). By comparison, the amplitude of the evoked IPSCs elicited by stimulation of the nRT was not significantly affected by THIP (88.32 ± 8.10% of control, n = 5 neurons; Fig. 5A ), indicating that the reduction in eSOC frequency was not due to a simple shunting of the membrane.
To further probe the role of d-subunit-containing receptors we compared eSOCs in d KO mice and WT littermates. In WT mice, hACSF application elicited eSOCs similar to those seen in rat VB TC neurons (3.01 ± 0.84 eSOCs ⁄ min, n = 4 neurons; Fig. 5B ). The number of eSOCs was significantly reduced in mice lacking the dsubunit (1.12 ± 0.49 eSOCs ⁄ min, n = 5 neurons, P < 0.05; Fig. 5B ), underlined also by the significant shift in the cumulative probability distribution for inter-event intervals (WT -8.94 ± 1.12 s, n = 150; d KO -22.86 ± 3.19 s, n = 83, P < 0.0001; Fig. 5C ). In addition, the kinetics of eSOCs were significantly different between the d KO and WT mice (WT s rise -66.27 ± 11.16 ms, n = 151; d KO s rise -29.43 ± 4.74 ms, n = 84, P < 0.001; WT s decay -74.19 ± 5.63 ms; d KO s decay -53.68 ± 3.63 ms, P < 0.05; Fig. 5C ).
Together, these data show that SOCs are generated by the activation of extrasynaptic d-subunit-containing GABA A receptors, as they are: (i) insensitive to the benzodiazepine site inverse agonist b-CCB, which specifically targets c2-subunit-containing synaptic receptors; (ii) sensitive to THIP, a preferential agonist at d-subunit-containing receptors; and (iii) less frequent in mice following the genetic ablation of the d-subunit.
The anti-epileptic vigabatrin augments SOCs
The lack of interneurons in the VB thalamus, the distinct properties of SOCs and IPSCs, and the evoking of SOCs by hypo-osmotic stimuli that are known to induce astrocytic transmitter release (Kimelberg et al., 2006) , along with a previous report showing that SOCs in the olfactory bulb are dependent on astrocytic GABA release (Kozlov et al., 2006) , all point to SOCs in TC neurons of the VB thalamus being generated by GABA released from astrocytes. Because GABA uptake transporters in the VB thalamus are only present on astrocytes (Barbaresi et al., 1986; De Biasi et al., 1998) , we hypothesized that inhibiting the catabolism of GABA by blocking the action of GABA transaminase (GABA-T) should increase astrocytic GABA levels and lead to an increase in SOCs, if they are indeed astrocytically derived. To test this hypothesis we used the GABA-T inhibitor and anti-epileptic vigabatrin. Treatment of slices with vigabatrin (200 lm) significantly increased both the frequency of sSOCs (control -0.09 ± 0.035 ⁄ min, n = 7 neurons; vigabatrin 0.35 ± 0.09 ⁄ min, n = 6 neurons; P < 0.05) and the frequency of eSOCs (control -2.95 ± 0.64 ⁄ min, n = 7 neurons; vigabatrin 6.21 ± 0.75 ⁄ min, n = 5 neurons; P < 0.005; Fig. 6A ). In addition, the time to peak (control -44.15 ± 3.40 ms, n = 102 events from seven neurons; vigabatrin 85.69 ± 14.33 ms, n = 194 events from five neurons; P < 0.001), but not the peak amplitude (control 184.34 ± 24.37 pA; vigabatrin 228.76 ± 24.17 pA; P > 0.05), of eSOCs was also significantly affected. There was also a trend in the frequency of both sSOCs and eSOCs to increase in a vigabatrin-treated time-dependent manner (sSOCs -R = 0.52, P = 0.07; eSOCs -R = 0.81, P < 0.005; Fig. 6C ). Conversely, as expected if the astrocyte-neuronal GABA cycle was perturbed, the frequency of IPSCs declined in a time-dependent manner (R = )0.88, P < 0.01), as previously described in dentate gyrus granule cells (Overstreet & Westbrook, 2001) , further highlighting the different sources of GABA mediating IPSCs and SOCs (Fig. 6C) .
We further probed the role of astrocytic GABA and GABA-T in the generation of SOCs by testing the hypothesis that promoting GABA uptake by increasing the extracellular GABA concentration should lead to a build-up of astrocytic GABA, so that there is more available for release. Slices were treated with 200 lm GABA in conjunction with 200 lm vigabatrin, and the frequency of sSOCs in treated slices was measured at varying time points. Increasing available GABA not only increased sSOC frequency (vigabatrin -0.35 ± 0.09 ⁄ min, n = 6 neurons; vigabatrin + GABA -3.56 ± 0.56 ⁄ min, n = 5 neurons; P < 0.005), but also the time-dependent correlation of sSOCs with vigabatrin treatment (R = 0.86, P < 0.001; Fig. 6B and C) . Previous studies with vigabatrin (Overstreet & Westbrook, 2001; Wu et al., 2001 Wu et al., , 2003 have suggested that increased intracellular GABA leads to reversal of GATs. We tested whether vigabatrin increased SOCs via reversal of GATs by applying the GAT-1-and GAT-3-selective blockers NO711 and SNAP5114. Co-application of NO711 (20 lm) and SNAP5114 (40 lm) increased the tonic GABA A current, consistent with the block of GABA uptake, but had no effect on the increase in frequency of sSOCs caused by treatment with vigabatrin and GABA (vigabatrin + GABA -1.25 ± 0.51 ⁄ min; NO711, SNAP5114, vigabatrin + GABA -1.09 ± 0.47 ⁄ min, n = 5 neurons; P > 0.05; Fig. 6D ). These data show that the increase in SOC frequency following vigabatrin treatment is not due to reversal of GATs, and that GABA uptake is unaffected as the block of GATs leads to an increase in the tonic GABA A current, not a reduction as would be expected if transporters were reversed.
Slow GABAergic hyperpolarizations
To determine the physiological manifestation and impact of SOCs, we recorded from VB TC neurons in current-clamp mode. Under control conditions we recorded two types of inhibitory activity: inhibitory postsynaptic potentials (IPSPs) and spindle waves. Both these have been previously described and shown to be derived from synaptic afferent activity emanating from the nRT onto VB TC neurons (Gentet & Ulrich, 2003) . IPSPs were seen as spontaneous transient events, caused a )2.3 ± 0.06 mV (n = 56) hyperpolarization and had a time to peak of 26.69 ± 0.51 ms. A mean IPSP averaged from 56 IPSPs had rise and decay fitted by a product of two exponentials (corr = 0.98 and 0.89, respectively; Fig. 7A ). Such IPSPs correspond to VB thalamus GABA release elicited by single nRT action potentials (APs) (Gentet & Ulrich, 2003) . However, nRT neurons also produce VB inhibitory hyperpolarizations by volleys of APs generated during nRT neuron bursting. Such recurrent bursts occur during spindles, which are 3-4 Hz oscillatory activity generated by intrathalamic networks between the inhibitory nRT neurons and excitatory TC neurons. We therefore analysed the inhibitory hyperpolarizing events occurring during spindles in VB TC neurons as a way of identifying inhibitory events generated as the result of nRT AP bursts.
Hyperpolarizations had an amplitude of )3.57 ± 0.16 mV (n = 46) and time to peak of 54 ± 0.93 ms. A mean spindle hyperpolarization averaged from 46 events had rise (correlation 0.98) and decay fitted by products of two exponentials (corr = 0.93; Fig. 7B) . To detect hyperpolarizations induced by SOCs we recorded in current-clamp in slices at 33 ºC that had been treated with 200 lm vigabatrin to increase sSOC frequency. In these recordings we observed slow hyperpolarizing potentials (SHPs) that hyperpolarized the membrane potential away from action potential threshold (Fig. 7C) . SHPs caused a )3.21 ± 0.34 mV (n = 27) hyperpolarization and respectively) on holding current and sSOC frequency in a TC neuron from a vigabatrin-pre-treated slice. Application of SR95531 (25 lm) abolishes the transporter blocker-induced increase in tonic GABA A current. The bar graphs on right show the effect of GABA transporter (GAT) blockers on tonic current amplitude (left) and sSOC frequency (right) in the presence of vigabatrin and GABA alone, and together with NO711 and SNAP5114. * indicates P < 0.05; *** indicates P < 0.005. had a time to peak of 129.61 ± 12.50 ms. A 'mean' SHP averaged from 27 SHPs recorded from five cells had rise and decay time constants that were fitted by single exponentials (s rise = 10.11 ms, corr = 1.00; s decay = 300 ms, corr = 0.92; Fig. 7B ), supporting the notion that SHPs are single events rather than compound bursts of synaptic activity. As expected if SHPs were generated by SOCs, application of SR95531 (20 lm) blocked all SHPs (Fig. 7C) . SOCs are therefore capable of modulating thalamic output through the generation of SHPs that reduce TC neuron excitability. The slower kinetics and the fitting of the rise time with a single exponential therefore distinguish SHPs from spindle hyperpolarizations and IPSPs (Fig. 7D) . The relationship between amplitude and area was steepest for SHPs ( Fig. 7D ; R: IPSP = 0.69, spindle = 0.85, SHP = 0.71, P < 0.001).
Discussion

Source of GABAergic SOCs
The comparatively simple anatomical and synaptic structure of the rodent VB thalamus, combined with the conspicuous lack of GABAergic interneurons, make it an attractive model for investigating astrocytic function and, in particular, gliotransmitter release. Our data from TC neurons show that SOCs are dependent on astrocytic GABA release. Firstly, SOCs, unlike IPSCs, are not dependent on action potentials, Ca 2+ entry or vesicular GABA release, indicating that they are non-synaptically derived. Although alternate non-synaptic neuronal GABA release mechanisms have been demonstrated (Koch & Magnusson, 2009) , and in the dLGN GABA can be released from interneuron dendrites (Acuna-Goycolea et al., 2008) , the absence of interneurons in the VB thalamus, coupled to the fact that dendritic GABA release is also vesicular and dependent on extracellular Ca 2+ , precludes this mechanism in accounting for our observations (Isaacson, 2001 ). Secondly, SOCs are induced by hypo-osmotic stimuli that are an established method for inducing astrocytic amino acid release (Kimelberg et al., 2006) , and the method employed in the olfactory bulb to elicit astrocytically mediated SOCs. Finally, selectively targeting astrocyte GABA cycling by promoting GABA uptake by GATs and inhibiting GABA catabolism increases the incidence of SOCs but concomitantly decreases IPSC frequency, providing further evidence that SOCs are astrocytically derived. The specific mechanism involved in astrocytic GABA release remains to be identified, but the most likely candidate is a volume-regulated anion channel, as previously implicated in the olfactory bulb (Kozlov et al., 2006) . Another candidate may be the recently described bestrophin channel (Lee et al., 2010) . However, our data do demonstrate that reversed GABA transport is not responsible for astrocytic GABA release, even in conditions where astrocytic GABA levels are elevated following block of GABA-T with vigabatrin or increased ambient GABA. This is in contrast to previous findings where reversed GABA transport has been observed under physiologically relevant conditions (Wu et al., 2007) , and in response to vigabatrin treatment (Wu et al., 2001 (Wu et al., , 2003 , although this is not a universal finding (Overstreet & Westbrook, 2001) .
Astrocytic GABA release targets of d-subunit-containing GABA A receptors
In addition to fast IPSCs and persistent tonic currents, TC neurons therefore exhibit a third type of GABA A receptor-mediated inhibition of intermediate duration, similar, but even slower, to the GABA A,slow IPSCs previously described in hippocampal and cortical pyramidal neurons that are mediated by an unusual GABAergic interneuron, the neurogliaform cell (Banks et al., 1998; Szabadics et al., 2007; Olah et al., 2009) . In the thalamus, astrocytically released GABA appears to target d-subunit-containing extrasynaptic GABA A receptors, rather than c2-subunit-containing synaptic receptors, as SOCs were insensitive to b-CCB, a benzodiazepine site, i.e. c2-subunit-specific, inverse agonist, but were sensitive to modulation by the d-subunit-selective agonist THIP, and were less frequent in mice lacking the d-subunit. However, SOCs were not completely abolished in d KO mice, but this is not surprising as extrasynaptic GABA A receptors of unknown composition are present in TC neurons of d KO mice and generate a residual tonic current (Cope et al., 2009; Herd et al., 2009) . Indeed, the subunit composition of this unknown receptor subtype may explain the difference in SOC kinetics between d KO and WT mice. To the best of our knowledge, therefore, this is the first demonstration that extrasynaptic GABA A receptors are more than simple detectors of ambient GABA, but can mediate distinct, transient events in response to GABA release, whatever the source. Furthermore, tonic current amplitude increased substantially in response to hypo-osmotically induced astrocytic GABA release, and there is every reason therefore to believe that, despite the relatively low incidence of sSOCs, astrocytes are a source of GABA for tonic GABA A currents under physiologically relevant conditions.
We suggest that the THIP-induced decrease in SOC frequency, but increase in amplitude, is due to the fact that THIP is a full agonist at d-subunit-containing receptors, whereas GABA is only a partial agonist (Brown et al., 2002; Storustovu & Ebert, 2006) . The persistent presence of THIP fully occupies the extrasynaptic receptors, not only generating a large tonic current, but also preventing the binding of GABA to the receptors for most of the time. Thus, THIP causes a decrease in SOC frequency. On rare occasions, however, enough GABA is released to displace THIP from the receptors, thereby enabling the generation of SOCs. Because a substantial quantity of GABA must be required to do this, only large events are observed, and so there is a bias toward larger events in the presence of THIP. In short, THIP competes against the endogenous agonist for occupancy of the receptors, and GABA only succeeds in activating the receptor when a suitably high concentration is released.
SOCs and GABA-T
The exacerbation of SOCs by vigabatrin highlights a potentially novel therapeutic action for this anti-epileptic drug. Indeed, the concentration used in our study (200 lm) is within the plasma concentration range seen in epileptic patients (132-518 lm; Sanchez- Alcaraz et al., 1996) . Vigabatrin remains a frontline treatment for a variety of seizure types (Wheless et al., 2007) , where increased GABAergic inhibition may be beneficial. However, vigabatrin treatment is contraindicated for typical absence epilepsy, the major form of epilepsy associated with cortico-TC networks. Indeed, vigabatrin has been shown to exacerbate seizures in human absence epilepsy (Lortie et al., 1993; Parker et al., 1998; Perucca et al., 1998) , and in rodent models that exhibit spike-and-wave discharges, the clinical hallmark of absence seizures (Vergnes et al., 1984; Hosford & Wang, 1997; Bouwman et al., 2007) . These observations are consistent with the finding that extrasynaptic GABA A receptor gain-of-function in the thalamus is sufficient to induce absence seizures (Cope et al., 2009) , and that administration of THIP can initiate spike-and-wave discharges (Fariello & Golden, 1987; Cope et al., 2009) . Because astrocytic GABA release also targets extrasynaptic receptors, SOCs may play an important pathological role in the appearance of absence seizures.
Physiological roles of astrocytic GABA release
Whilst synaptic and, to a lesser extent, extrasynaptic GABA signalling in the thalamus has been extensively studied, the physiological roles of astrocytic GABA release in the thalamus are unclear. In our study, we demonstrate that SOCs can occur spontaneously and have a physiological impact, generating SHPs that reduce TC neuron excitability through membrane hyperpolarization, and probably membrane shunting. SOCs therefore have the potential to shape TC neuron output.
It is noteworthy that the incidence of SOCs in thalamic nuclei is inversely proportional to the presence of GABAergic neurons, with SOCs more prevalent in the VB thalamus, a nucleus devoid of thalamic interneurons, compared with the dLGN, and rarely occurring in the nRT, which contains only GABAergic neurons. Despite the apparent low frequency of spontaneously occurring SOCs, which might suggest that they are not physiologically relevant, their increased incidence with age, and capacity to be upregulated by GABA supply indicates that they may also be upregulated in some physiological or pathophysiological conditions. Indeed by analogy with other gliotransmitters (Parri et al., 2001; Henneberger et al., 2010) , it may also be expected that certain neurotransmitter systems act to elicit astrocytic GABA release. Astrocytes may therefore function as inhibitory cellular elements, and some of the roles of thalamic GABAergic neurons may be adopted by astrocytes in the VB thalamus. In this context, astrocytic glutamate release, which generates SICs in the thalamus (Parri et al., 2001) , has been shown to participate in local, synchronized excitation of neurons in the hippocampus (Angulo et al., 2004; Fellin et al., 2004) and nucleus accumbens (D'Ascenzo et al., 2007) , probably via extrasynaptic receptors. SOCs may therefore be a mechanism for local, synchronized inhibition of neurons as astrocytic GABA release would be expected to affect multiple neurons within their domain (Halassa et al., 2007) . Furthermore, abnormal astrocytic glutamate release may underlie neuronal hypersynchronization (Tian et al., 2005) , and therefore aberrant astrocytic GABA release may also be pathological. Indeed the physiological roles of extrasynaptic receptors are becoming increasingly apparent, and aberrant extrasynaptic receptor function occurs in several pathophysiological conditions (Maguire et al., 2005; Naylor et al., 2005; Scimemi et al., 2005; Cope et al., 2009; Pavlov et al., 2009; Rothman et al., 2009) . However, the contribution of astrocytic GABA signalling to these physiological and pathological behaviours has yet to be determined.
In conclusion, our study describes a previously unrecognized form of astrocyte-neuron GABA signalling in the thalamus that specifically targets extrasynaptic GABA A receptors. Whilst the physiological roles of this signalling remain to be elucidated, its augmentation by vigabatrin suggests that astrocytic GABA release may be a therapeutic target for some anti-epileptics, further highlighting the importance of glia in both physiological and pathophysiological processes in the CNS.
